The global Carprofen market was valued at US$ 73 million in 2023 and is anticipated to reach US$ 97.2 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.

Carprofen Market

Carprofen is a nonsteroidal anti-inflammatory drug (NSAID) that veterinarians prescribe as a supportive treatment for various conditions in animals. It provides day-to-day treatment for pain and inflammation from various kinds of joint pain as well as post-operative pain.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Carprofen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carprofen.

Report Scope

The Carprofen market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Carprofen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Carprofen manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Carprofen Market Report

Report Metric	Details
Report Name	Carprofen Market
Accounted market size in 2023	US$ 73 million
Forecasted market size in 2030	US$ 97.2 million
CAGR	3.7%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Ibuprofen Naproxen Ketoprofen
Segment by Application	Dog Cat Horse Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Zoetis, Chanelle Pharma, AVENTIX, KRKA UK Ltd, Dechra, Parnell, VetUK, Norbrook, Alivira Animal Health, Vedco Inc, ElancoDVM, Vethical, Vetoquinol, Pivetal
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Carprofen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Carprofen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Carprofen Market growing?

Ans: The Carprofen Market witnessing a CAGR of 3.7% during the forecast period 2024-2030.

What is the Carprofen Market size in 2030?

Ans: The Carprofen Market size in 2030 will be US$ 97.2 million.

Who are the main players in the Carprofen Market report?

Ans: The main players in the Carprofen Market are Zoetis, Chanelle Pharma, AVENTIX, KRKA UK Ltd, Dechra, Parnell, VetUK, Norbrook, Alivira Animal Health, Vedco Inc, ElancoDVM, Vethical, Vetoquinol, Pivetal

What are the Application segmentation covered in the Carprofen Market report?

Ans: The Applications covered in the Carprofen Market report are Dog, Cat, Horse, Others

What are the Type segmentation covered in the Carprofen Market report?

Ans: The Types covered in the Carprofen Market report are Ibuprofen, Naproxen, Ketoprofen

1 Carprofen Market Overview

1.1 Product Overview and Scope of Carprofen

1.2 Carprofen Segment by Type

1.2.1 Global Carprofen Market Value Comparison by Type (2024-2030)

1.2.2 Ibuprofen

1.2.3 Naproxen

1.2.4 Ketoprofen

1.3 Carprofen Segment by Application

1.3.1 Global Carprofen Market Value by Application: (2024-2030)

1.3.2 Dog

1.3.3 Cat

1.3.4 Horse

1.3.5 Others

1.4 Global Carprofen Market Size Estimates and Forecasts

1.4.1 Global Carprofen Revenue 2019-2030

1.4.2 Global Carprofen Sales 2019-2030

1.4.3 Global Carprofen Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Carprofen Market Competition by Manufacturers

2.1 Global Carprofen Sales Market Share by Manufacturers (2019-2024)

2.2 Global Carprofen Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Carprofen Average Price by Manufacturers (2019-2024)

2.4 Global Carprofen Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Carprofen, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Carprofen, Product Type & Application

2.7 Carprofen Market Competitive Situation and Trends

2.7.1 Carprofen Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Carprofen Players Market Share by Revenue

2.7.3 Global Carprofen Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Carprofen Retrospective Market Scenario by Region

3.1 Global Carprofen Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Carprofen Global Carprofen Sales by Region: 2019-2030

3.2.1 Global Carprofen Sales by Region: 2019-2024

3.2.2 Global Carprofen Sales by Region: 2025-2030

3.3 Global Carprofen Global Carprofen Revenue by Region: 2019-2030

3.3.1 Global Carprofen Revenue by Region: 2019-2024

3.3.2 Global Carprofen Revenue by Region: 2025-2030

3.4 North America Carprofen Market Facts & Figures by Country

3.4.1 North America Carprofen Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Carprofen Sales by Country (2019-2030)

3.4.3 North America Carprofen Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Carprofen Market Facts & Figures by Country

3.5.1 Europe Carprofen Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Carprofen Sales by Country (2019-2030)

3.5.3 Europe Carprofen Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Carprofen Market Facts & Figures by Country

3.6.1 Asia Pacific Carprofen Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Carprofen Sales by Country (2019-2030)

3.6.3 Asia Pacific Carprofen Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Carprofen Market Facts & Figures by Country

3.7.1 Latin America Carprofen Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Carprofen Sales by Country (2019-2030)

3.7.3 Latin America Carprofen Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Carprofen Market Facts & Figures by Country

3.8.1 Middle East and Africa Carprofen Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Carprofen Sales by Country (2019-2030)

3.8.3 Middle East and Africa Carprofen Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Carprofen Sales by Type (2019-2030)

4.1.1 Global Carprofen Sales by Type (2019-2024)

4.1.2 Global Carprofen Sales by Type (2025-2030)

4.1.3 Global Carprofen Sales Market Share by Type (2019-2030)

4.2 Global Carprofen Revenue by Type (2019-2030)

4.2.1 Global Carprofen Revenue by Type (2019-2024)

4.2.2 Global Carprofen Revenue by Type (2025-2030)

4.2.3 Global Carprofen Revenue Market Share by Type (2019-2030)

4.3 Global Carprofen Price by Type (2019-2030)

5 Segment by Application

5.1 Global Carprofen Sales by Application (2019-2030)

5.1.1 Global Carprofen Sales by Application (2019-2024)

5.1.2 Global Carprofen Sales by Application (2025-2030)

5.1.3 Global Carprofen Sales Market Share by Application (2019-2030)

5.2 Global Carprofen Revenue by Application (2019-2030)

5.2.1 Global Carprofen Revenue by Application (2019-2024)

5.2.2 Global Carprofen Revenue by Application (2025-2030)

5.2.3 Global Carprofen Revenue Market Share by Application (2019-2030)

5.3 Global Carprofen Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Zoetis

6.1.1 Zoetis Corporation Information

6.1.2 Zoetis Description and Business Overview

6.1.3 Zoetis Carprofen Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Zoetis Carprofen Product Portfolio

6.1.5 Zoetis Recent Developments/Updates

6.2 Chanelle Pharma

6.2.1 Chanelle Pharma Corporation Information

6.2.2 Chanelle Pharma Description and Business Overview

6.2.3 Chanelle Pharma Carprofen Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Chanelle Pharma Carprofen Product Portfolio

6.2.5 Chanelle Pharma Recent Developments/Updates

6.3 AVENTIX

6.3.1 AVENTIX Corporation Information

6.3.2 AVENTIX Description and Business Overview

6.3.3 AVENTIX Carprofen Sales, Revenue and Gross Margin (2019-2024)

6.3.4 AVENTIX Carprofen Product Portfolio

6.3.5 AVENTIX Recent Developments/Updates

6.4 KRKA UK Ltd

6.4.1 KRKA UK Ltd Corporation Information

6.4.2 KRKA UK Ltd Description and Business Overview

6.4.3 KRKA UK Ltd Carprofen Sales, Revenue and Gross Margin (2019-2024)

6.4.4 KRKA UK Ltd Carprofen Product Portfolio

6.4.5 KRKA UK Ltd Recent Developments/Updates

6.5 Dechra

6.5.1 Dechra Corporation Information

6.5.2 Dechra Description and Business Overview

6.5.3 Dechra Carprofen Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Dechra Carprofen Product Portfolio

6.5.5 Dechra Recent Developments/Updates

6.6 Parnell

6.6.1 Parnell Corporation Information

6.6.2 Parnell Description and Business Overview

6.6.3 Parnell Carprofen Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Parnell Carprofen Product Portfolio

6.6.5 Parnell Recent Developments/Updates

6.7 VetUK

6.6.1 VetUK Corporation Information

6.6.2 VetUK Description and Business Overview

6.6.3 VetUK Carprofen Sales, Revenue and Gross Margin (2019-2024)

6.4.4 VetUK Carprofen Product Portfolio

6.7.5 VetUK Recent Developments/Updates

6.8 Norbrook

6.8.1 Norbrook Corporation Information

6.8.2 Norbrook Description and Business Overview

6.8.3 Norbrook Carprofen Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Norbrook Carprofen Product Portfolio

6.8.5 Norbrook Recent Developments/Updates

6.9 Alivira Animal Health

6.9.1 Alivira Animal Health Corporation Information

6.9.2 Alivira Animal Health Description and Business Overview

6.9.3 Alivira Animal Health Carprofen Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Alivira Animal Health Carprofen Product Portfolio

6.9.5 Alivira Animal Health Recent Developments/Updates

6.10 Vedco Inc

6.10.1 Vedco Inc Corporation Information

6.10.2 Vedco Inc Description and Business Overview

6.10.3 Vedco Inc Carprofen Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Vedco Inc Carprofen Product Portfolio

6.10.5 Vedco Inc Recent Developments/Updates

6.11 ElancoDVM

6.11.1 ElancoDVM Corporation Information

6.11.2 ElancoDVM Carprofen Description and Business Overview

6.11.3 ElancoDVM Carprofen Sales, Revenue and Gross Margin (2019-2024)

6.11.4 ElancoDVM Carprofen Product Portfolio

6.11.5 ElancoDVM Recent Developments/Updates

6.12 Vethical

6.12.1 Vethical Corporation Information

6.12.2 Vethical Carprofen Description and Business Overview

6.12.3 Vethical Carprofen Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Vethical Carprofen Product Portfolio

6.12.5 Vethical Recent Developments/Updates

6.13 Vetoquinol

6.13.1 Vetoquinol Corporation Information

6.13.2 Vetoquinol Carprofen Description and Business Overview

6.13.3 Vetoquinol Carprofen Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Vetoquinol Carprofen Product Portfolio

6.13.5 Vetoquinol Recent Developments/Updates

6.14 Pivetal

6.14.1 Pivetal Corporation Information

6.14.2 Pivetal Carprofen Description and Business Overview

6.14.3 Pivetal Carprofen Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Pivetal Carprofen Product Portfolio

6.14.5 Pivetal Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Carprofen Industry Chain Analysis

7.2 Carprofen Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Carprofen Production Mode & Process

7.4 Carprofen Sales and Marketing

7.4.1 Carprofen Sales Channels

7.4.2 Carprofen Distributors

7.5 Carprofen Customers

8 Carprofen Market Dynamics

8.1 Carprofen Industry Trends

8.2 Carprofen Market Drivers

8.3 Carprofen Market Challenges

8.4 Carprofen Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Alivira Animal Health

List of Tables

Table 1. Global Carprofen Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Carprofen Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Carprofen Market Competitive Situation by Manufacturers in 2023

Table 4. Global Carprofen Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Carprofen Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Carprofen Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Carprofen Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Carprofen Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Carprofen, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Carprofen, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Carprofen, Product Type & Application

Table 12. Global Key Manufacturers of Carprofen, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Carprofen by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carprofen as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Carprofen Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Carprofen Sales by Region (2019-2024) & (K Units)

Table 18. Global Carprofen Sales Market Share by Region (2019-2024)

Table 19. Global Carprofen Sales by Region (2025-2030) & (K Units)

Table 20. Global Carprofen Sales Market Share by Region (2025-2030)

Table 21. Global Carprofen Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Carprofen Revenue Market Share by Region (2019-2024)

Table 23. Global Carprofen Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Carprofen Revenue Market Share by Region (2025-2030)

Table 25. North America Carprofen Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Carprofen Sales by Country (2019-2024) & (K Units)

Table 27. North America Carprofen Sales by Country (2025-2030) & (K Units)

Table 28. North America Carprofen Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Carprofen Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Carprofen Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Carprofen Sales by Country (2019-2024) & (K Units)

Table 32. Europe Carprofen Sales by Country (2025-2030) & (K Units)

Table 33. Europe Carprofen Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Carprofen Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Carprofen Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Carprofen Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Carprofen Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Carprofen Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Carprofen Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Carprofen Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Carprofen Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Carprofen Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Carprofen Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Carprofen Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Carprofen Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Carprofen Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Carprofen Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Carprofen Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Carprofen Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Carprofen Sales (K Units) by Type (2019-2024)

Table 51. Global Carprofen Sales (K Units) by Type (2025-2030)

Table 52. Global Carprofen Sales Market Share by Type (2019-2024)

Table 53. Global Carprofen Sales Market Share by Type (2025-2030)

Table 54. Global Carprofen Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Carprofen Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Carprofen Revenue Market Share by Type (2019-2024)

Table 57. Global Carprofen Revenue Market Share by Type (2025-2030)

Table 58. Global Carprofen Price (US$/Unit) by Type (2019-2024)

Table 59. Global Carprofen Price (US$/Unit) by Type (2025-2030)

Table 60. Global Carprofen Sales (K Units) by Application (2019-2024)

Table 61. Global Carprofen Sales (K Units) by Application (2025-2030)

Table 62. Global Carprofen Sales Market Share by Application (2019-2024)

Table 63. Global Carprofen Sales Market Share by Application (2025-2030)

Table 64. Global Carprofen Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Carprofen Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Carprofen Revenue Market Share by Application (2019-2024)

Table 67. Global Carprofen Revenue Market Share by Application (2025-2030)

Table 68. Global Carprofen Price (US$/Unit) by Application (2019-2024)

Table 69. Global Carprofen Price (US$/Unit) by Application (2025-2030)

Table 70. Zoetis Corporation Information

Table 71. Zoetis Description and Business Overview

Table 72. Zoetis Carprofen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Zoetis Carprofen Product

Table 74. Zoetis Recent Developments/Updates

Table 75. Chanelle Pharma Corporation Information

Table 76. Chanelle Pharma Description and Business Overview

Table 77. Chanelle Pharma Carprofen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Chanelle Pharma Carprofen Product

Table 79. Chanelle Pharma Recent Developments/Updates

Table 80. AVENTIX Corporation Information

Table 81. AVENTIX Description and Business Overview

Table 82. AVENTIX Carprofen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. AVENTIX Carprofen Product

Table 84. AVENTIX Recent Developments/Updates

Table 85. KRKA UK Ltd Corporation Information

Table 86. KRKA UK Ltd Description and Business Overview

Table 87. KRKA UK Ltd Carprofen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. KRKA UK Ltd Carprofen Product

Table 89. KRKA UK Ltd Recent Developments/Updates

Table 90. Dechra Corporation Information

Table 91. Dechra Description and Business Overview

Table 92. Dechra Carprofen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Dechra Carprofen Product

Table 94. Dechra Recent Developments/Updates

Table 95. Parnell Corporation Information

Table 96. Parnell Description and Business Overview

Table 97. Parnell Carprofen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Parnell Carprofen Product

Table 99. Parnell Recent Developments/Updates

Table 100. VetUK Corporation Information

Table 101. VetUK Description and Business Overview

Table 102. VetUK Carprofen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. VetUK Carprofen Product

Table 104. VetUK Recent Developments/Updates

Table 105. Norbrook Corporation Information

Table 106. Norbrook Description and Business Overview

Table 107. Norbrook Carprofen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Norbrook Carprofen Product

Table 109. Norbrook Recent Developments/Updates

Table 110. Alivira Animal Health Corporation Information

Table 111. Alivira Animal Health Description and Business Overview

Table 112. Alivira Animal Health Carprofen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Alivira Animal Health Carprofen Product

Table 114. Alivira Animal Health Recent Developments/Updates

Table 115. Vedco Inc Corporation Information

Table 116. Vedco Inc Description and Business Overview

Table 117. Vedco Inc Carprofen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Vedco Inc Carprofen Product

Table 119. Vedco Inc Recent Developments/Updates

Table 120. ElancoDVM Corporation Information

Table 121. ElancoDVM Description and Business Overview

Table 122. ElancoDVM Carprofen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. ElancoDVM Carprofen Product

Table 124. ElancoDVM Recent Developments/Updates

Table 125. Vethical Corporation Information

Table 126. Vethical Description and Business Overview

Table 127. Vethical Carprofen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Vethical Carprofen Product

Table 129. Vethical Recent Developments/Updates

Table 130. Vetoquinol Corporation Information

Table 131. Vetoquinol Description and Business Overview

Table 132. Vetoquinol Carprofen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Vetoquinol Carprofen Product

Table 134. Vetoquinol Recent Developments/Updates

Table 135. Pivetal Corporation Information

Table 136. Pivetal Description and Business Overview

Table 137. Pivetal Carprofen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Pivetal Carprofen Product

Table 139. Pivetal Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Carprofen Distributors List

Table 143. Carprofen Customers List

Table 144. Carprofen Market Trends

Table 145. Carprofen Market Drivers

Table 146. Carprofen Market Challenges

Table 147. Carprofen Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Carprofen

Figure 2. Global Carprofen Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Carprofen Market Share by Type in 2023 & 2030

Figure 4. Ibuprofen Product Picture

Figure 5. Naproxen Product Picture

Figure 6. Ketoprofen Product Picture

Figure 7. Global Carprofen Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Carprofen Market Share by Application in 2023 & 2030

Figure 9. Dog

Figure 10. Cat

Figure 11. Horse

Figure 12. Others

Figure 13. Global Carprofen Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Carprofen Market Size (2019-2030) & (US$ Million)

Figure 15. Global Carprofen Sales (2019-2030) & (K Units)

Figure 16. Global Carprofen Average Price (US$/Unit) & (2019-2030)

Figure 17. Carprofen Report Years Considered

Figure 18. Carprofen Sales Share by Manufacturers in 2023

Figure 19. Global Carprofen Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Carprofen Players: Market Share by Revenue in 2023

Figure 21. Carprofen Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Carprofen Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Carprofen Sales Market Share by Country (2019-2030)

Figure 24. North America Carprofen Revenue Market Share by Country (2019-2030)

Figure 25. U.S. Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Carprofen Sales Market Share by Country (2019-2030)

Figure 28. Europe Carprofen Revenue Market Share by Country (2019-2030)

Figure 29. Germany Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Carprofen Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Carprofen Revenue Market Share by Region (2019-2030)

Figure 36. China Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Taiwan Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Philippines Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Carprofen Sales Market Share by Country (2019-2030)

Figure 47. Latin America Carprofen Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Carprofen Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Carprofen Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. U.A.E Carprofen Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Carprofen by Type (2019-2030)

Figure 57. Global Revenue Market Share of Carprofen by Type (2019-2030)

Figure 58. Global Carprofen Price (US$/Unit) by Type (2019-2030)

Figure 59. Global Sales Market Share of Carprofen by Application (2019-2030)

Figure 60. Global Revenue Market Share of Carprofen by Application (2019-2030)

Figure 61. Global Carprofen Price (US$/Unit) by Application (2019-2030)

Figure 62. Carprofen Value Chain

Figure 63. Carprofen Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions